{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:06:20Z","timestamp":1791446780745,"version":"4.3.3"},"reference-count":65,"publisher":"Cardiofront, LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.4022\/jafib.1524","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T07:39:09Z","timestamp":1513064349000},"source":"Crossref","is-referenced-by-count":11,"title":["Percutaneous Left Atrial Appendage Closure: is there a Role in Valvular Atrial Fibrillation"],"prefix":"10.4022","volume":"9","author":[{"given":"Chetan","family":"Huded","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Krishnaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2440","published-online":{"date-parts":[[2017,2,28]]},"reference":[{"key":"key_R01","first-page":"869","article-title":"Left atrial appendage occlusion: rationale, evidence, devices, and patient selection.","volume-title":"Eur. Heart J.","year":"2017"},{"key":"key_R02","first-page":"0","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO)","volume-title":"Eur J Cardiothorac Surg","year":"2016"},{"key":"key_R03","first-page":"530","article-title":"How to define valvular atrial fibrillation?","volume":"108 (10)","year":"2015","journal-title":"Arch Cardiovasc Dis"},{"key":"key_R04","first-page":"47","article-title":"Management of atrial fibrillation in rheumatic valvular heart disease.","volume":"21 (1)","year":"2006","journal-title":"Curr. Opin. Cardiol."},{"key":"key_R05","first-page":"3328","article-title":"What is 'valvular' atrial fibrillation? A reappraisal.","volume":"35 (47)","year":"2014","journal-title":"Eur. Heart J."},{"key":"key_R06","first-page":"534","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.","volume":"374 (9689)","year":"2009","journal-title":"Lancet"},{"key":"key_R07","first-page":"1825","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation.","volume":"347 (23)","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"key_R08","first-page":"263","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.","volume":"137 (2)","year":"2010","journal-title":"Chest"},{"key":"key_R09","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.","volume":"8 (5)","year":"2013","journal-title":"PLoS ONE"},{"key":"key_R10","first-page":"1093","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.","volume":"138 (5)","year":"2010","journal-title":"Chest"},{"key":"key_R11","first-page":"1","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.","volume":"64 (1)","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"key_R12","first-page":"1139","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation.","volume":"361 (12)","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"key_R13","first-page":"981","article-title":"Apixaban versus warfarin in patients with atrial fibrillation.","volume":"365 (11)","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"key_R14","first-page":"883","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.","volume":"365 (10)","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"key_R15","first-page":"76","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key_R16","first-page":"21","article-title":"Novel oral anticoagulants and valvular atrial fibrillation: are they always contraindicated?","volume":"10 (1)","year":"2015","journal-title":"Intern Emerg Med"},{"key":"key_R17","first-page":"1067","article-title":"Atrial fibrillation.","volume":"344 (14)","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"key_R18","first-page":"1720","article-title":"The definition of valvular and non-valvular atrial fibrillation: results of a physicians' survey.","volume-title":"Europace","year":"2014"},{"key":"key_R19","first-page":"983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.","volume-title":"Stroke","year":"1991"},{"key":"key_R20","first-page":"937","article-title":"Atrial fibrillation and stroke: new ideas, persisting dilemmas.","volume":"19 (8)","year":"1988","journal-title":"Stroke"},{"key":"key_R21","first-page":"973","article-title":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.","volume":"28 (10)","year":"1978","journal-title":"Neurology"},{"key":"key_R22","first-page":"6","article-title":"Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial.","volume":"18 (1)","year":"2016","journal-title":"Europace"},{"key":"key_R23","first-page":"40","article-title":"Frequency of left atrial and appendage clot in patients with severe mitral stenosis.","volume":"22 (2)","year":"2010","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"key_R24","first-page":"528","article-title":"Mitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation.","volume":"136 (3)","year":"1998","journal-title":"Am. Heart J."},{"key":"key_R25","first-page":"235","article-title":"Mitral regurgitation and atrial fibrillation: milder the disease, higher the risk?","volume":"72 (3)","year":"2000","journal-title":"Int. J. Cardiol."},{"key":"key_R26","first-page":"998","article-title":"Reduced risk for thromboembolism in atrial fibrillation and mitral regurgitation.","volume":"138 (5 Pt 1)","year":"1999","journal-title":"Am. Heart J."},{"key":"key_R27","first-page":"358","article-title":"Prevalence of left atrial thrombus in rheumatic mitral stenosis with atrial fibrillation and its response to anticoagulation: a transesophageal echocardiographic study.","volume":"55 (4)","year":"2003","journal-title":"Indian Heart J"},{"key":"key_R28","first-page":"755","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.","volume":"61 (2)","year":"1996","journal-title":"Ann. Thorac. Surg."},{"key":"key_R29","first-page":"95","article-title":"Structural remodeling of the left atrial appendage in patients with chronic non-valvular atrial fibrillation: Implications for thrombus formation, systemic embolism, and assessment by transesophageal echocardiography.","volume":"9 (2)","year":"2000","journal-title":"Cardiovasc. Pathol."},{"key":"key_R30","first-page":"319","article-title":"Light and electron microscopic features of surgically excised left atrial appendage in rheumatic heart disease patients with atrial fibrillation and sinus rhythm.","volume":"23 (6)","year":"2014","journal-title":"Cardiovasc. Pathol."},{"key":"key_R31","article-title":"Role of Endovascular Closure of the Left Atrial Appendage in Stroke Prevention for Atrial Fibrillation.","volume":"17 (11)","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"key_R32","first-page":"2193","article-title":"Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation.","volume":"155 (20)","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"key_R33","first-page":"306","article-title":"Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion?","volume":"10 (2)","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"key_R34","first-page":"847","article-title":"Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis.","volume":"47 (5)","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"key_R35","first-page":"45","article-title":"Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III.","volume-title":"Ann Cardiothorac Surg","year":"2014"},{"key":"key_R36","first-page":"9","article-title":"Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.","volume-title":"J. Am. Coll. Cardiol.","year":"2005"},{"key":"key_R37","first-page":"8","article-title":"Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.","volume":"71 (1)","year":"2013","journal-title":"Kardiol Pol"},{"key":"key_R38","first-page":"167","article-title":"Safety and Efficacy of Left Atrial Appendage Closure with the Amplatzer Cardiac Plug in Very High Stroke and Bleeding Risk Patients with Non-Valvular Atrial Fibrillation.","volume":"4 (2)","year":"2015","journal-title":"Cardiol Ther"},{"key":"key_R39","first-page":"219","article-title":"Left atrial appendage occlusion with Amplatzer Cardio Plug is an acceptable therapeutic option for prevention of stroke recurrence in patients with non-valvular atrial fibrillation and contraindication or failure of oral anticoagulation with acenocumarol.","volume":"74 (3)","year":"2016","journal-title":"Arq Neuropsiquiatr"},{"key":"key_R40","first-page":"1170","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug.","volume":"11 (10)","year":"2016","journal-title":"EuroIntervention"},{"key":"key_R41","first-page":"565","article-title":"Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium.","volume":"64 (6)","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"key_R42","first-page":"979","article-title":"Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin.","volume":"18 (7)","year":"2016","journal-title":"Europace"},{"key":"key_R43","first-page":"1790","article-title":"Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation.","volume":"61 (17)","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"key_R44","first-page":"2551","article-title":"Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).","volume":"61 (25)","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"key_R45","article-title":"Left Atrial Appendage Closure -The WATCHMAN Device.","volume":"()","year":"2015","journal-title":"Curr Cardiol Rev"},{"key":"key_R46","first-page":"2614","article-title":"Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.","volume":"65 (24)","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"key_R47","first-page":"1915","article-title":"Percutaneous Left Atrial Appendage Closure With the Watchman Device: Long-Term Results Up to 5 Years.","volume":"8 (15)","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"key_R48","first-page":"2465","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry.","volume":"37 (31)","year":"2016","journal-title":"Eur. Heart J."},{"key":"key_R49","first-page":"787","article-title":"Left atrial appendage closure: First in man with the 4th generation WATCHMAN device.","volume":"87 (4)","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"key_R50","first-page":"393","article-title":"Learning Curve Assessment for Percutaneous Left Atrial Appendage Closure With the WATCHMAN Occluder.","volume":"29 (4)","year":"2016","journal-title":"J Interv Cardiol"},{"key":"key_R51","first-page":"1988","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.","volume":"312 (19)","year":"2014","journal-title":"JAMA"},{"key":"key_R52","first-page":"393","article-title":"Left atrial appendage occlusion in valvular atrial fibrillation following MitraClip implantation.","volume":"101 (5)","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"key_R53","first-page":"428","article-title":"Combined percutaneous balloon mitral valvuloplasty and left atrial appendage occlusion device implantation for rheumatic mitral stenosis and atrial fibrillation.","volume":"15 (8)","year":"2014","journal-title":"Cardiovasc Revasc Med"},{"key":"key_R54","first-page":"E32","article-title":"Two in a single procedure: combined approach for MitraClip implantation and left atrial appendage occlusion using the Watchman device.","volume":"26 (3)","year":"2014","journal-title":"J Invasive Cardiol"},{"key":"key_R55","first-page":"1253","article-title":"Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study.","volume":"42 (7)","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"key_R56","first-page":"2700","article-title":"Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit.","volume":"33 (21)","year":"2012","journal-title":"Eur. Heart J."},{"key":"key_R57","first-page":"806","article-title":"Apixaban in patients with atrial fibrillation.","volume":"364 (9)","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"key_R58","first-page":"2093","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation.","volume":"369 (22)","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"key_R59","first-page":"163","article-title":"Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus.","volume":"7 (1)","year":"1986","journal-title":"J. Am. Coll. Cardiol."},{"key":"key_R60","first-page":"677","article-title":"Diagnostic accuracy of transesophageal echocardiography for detecting left atrial thrombi in patients with rheumatic heart disease having undergone mitral valve operations.","volume":"72 (9)","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"key_R61","first-page":"270","article-title":"Location, size and morphological characteristics of left atrial thrombi as assessed by echocardiography in patients with rheumatic mitral valve disease.","volume":"2 (4)","year":"2001","journal-title":"Eur J Echocardiogr"},{"key":"key_R62","first-page":"770","article-title":"Feasibility of LAA Closure for Left Atrial Thrombus in\u00a0Patients With Aortic Stenosis and AF.","volume":"68 (7)","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"key_R63","first-page":"124","article-title":"Left atrial appendage resection versus preservation during the surgical ablation of atrial fibrillation.","volume":"97 (1)","year":"2014","journal-title":"Ann. Thorac. Surg."},{"key":"key_R64","first-page":"553","article-title":"Concurrent prophylactic left atrial appendage exclusion: results from a randomized controlled trial pilot study.","volume":"36 (3)","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"key_R65","first-page":"371","article-title":"Epicardial surgical ligation of the left atrial appendage is safe, reproducible, and effective by transesophageal echocardiographic follow-up.","volume":"8 (5)","year":"2013","journal-title":"Innovations (Phila)"}],"container-title":["Journal of Atrial Fibrillation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T07:39:09Z","timestamp":1513064349000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jafib.com\/published.php?type=full&id=1524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":65,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,2,28]]},"published-print":{"date-parts":[[2017]]}},"alternative-id":["10.4022\/jafib.1524"],"URL":"https:\/\/doi.org\/10.4022\/jafib.1524","relation":{},"ISSN":["1941-6911"],"issn-type":[{"value":"1941-6911","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]},"article-number":"1524"}}